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Purpose: This paper presents an improved kinetic-spectrophotometric procedure for determining 
clonazepam (CZP) in pharmaceutical formulations and human serum.  
Methods: The method is based on ligand-exchange reaction. The reaction was followed 
spectrophotometrically by measuring the rate of change of absorbance at 425 nm in ethanolic sodium 
hydroxide solution.  
Results: The optimum operating conditions for reagent concentrations and temperature were 
established. Linear calibration curve was obtained in the range of 0.32 - 4.10 µg mL
-1
. The optimized 
conditions yielded a theoretical detection limit of 0.24 µg mL
-1
 based on the 3.3So criterion, where S0 is 
standard deviation of the calibration line. The interference of certain drugs, foreign ions and amino acids 
on the reaction rate were studied in order to assess the selectivity of the method.  
Conclusion: The developed method is sensitive, accurate and reproducible and could be used for 
routine anlysis of clonazepam in pharmaceutical preparations and serum samples. 
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INTRODUCTION 
 
Clonazepam is an anticonvulsant agent 
widely used in the treatment of epilepsy in 
adults and children [1]. As a result of the 
therapeutic importance and widespread use 
of this compound, the literature contains 
many reports dealing with its determination. 
For the biopharmacological, clinical and 
toxicological studies of these drugs, a rapid, 
sensitive and selective analytical method for 
its determination is essential. 
 
The British Pharmacopoeia [2] recommends 
non-aqueous titration with perchloric acid for 
the determination of clonazepam. For dosage 
forms, high-pressure liquid chromatography 
(HPLC) is recommended by US 
Pharmacopoeia [3]. Several methods for the 
assay of this compound have been reported 
by many authors, e.g., spectrometric 
methods [4-6], potentiometric methods [7,8], 
voltammetry [9], polarography [10], HPLC 
[10-12], gas chromatography coupled with 
mass spectrometry (GC-MS) [11,13]. 
 
The present work describes a kinetic method 
for the determination of clonazepam (CZP) in 
commercial pharmaceutical preparations and 
human serum. The method is based on 
ligand-exchange reaction. This type of 
reactions is recent and has not been studied 
much. The procedure is easier to execute, 
does not need sophisticated instruments or 
special skill, and requires less sample 
handling than methods currently described in 






Perkin-Elmer Lambda 15 UV/Vis 
spectrophotometer equipped with kinetic 
accessory provided with a temperature 
controlled cell. A model 1200 Agilent 
Technologies was used for HPLC analysis. 









clonazepam was prepared in absolute 
ethanol from clonazepam powder (certified 
purity: 99.92 %), kindly provided by Galenika, 
a.d., Belgrade, Serbia. The solution was 
stored at 4 ºC. Analytical reagent grade 
chemicals and deionised water (MicroMed 
high purity water system, TKA 
Wasseraufbereitungssysteme GmbH) were 
used for the preparation of all solutions. 
Sodium hydroxide solution (NaOH, 1.0 mol L
-
1






(Merck) was prepared by dissolving a known 
amount (0.0086 g) of this reagent in 5 ml 
absolute ethanol and diluting it with water 
(total volume 50 mL). 
 





was prepared by dissolving CoCl2.6H2O 





) was obtained by appropriately 
diluting the stock cobalt solution with water. 
The ionic strength of the reaction mixture was 
kept constant at 0.1 by adding to the mixture 





All the glassware used were washed with 
aqueous HCl (1:1) and then thoroughly rinsed 
with running, distilled water, and then finally 




In order to obtain good mechanical and 
thermal stability, the instruments were run for 
10 min prior to the first measurement. The 
reaction was carried out as follows. In the 
reaction - mixture vessel with four 
compartments, the solution of 1-nitroso-2-
naphthol was placed in one compartment, 
sodium hydroxide in the second, clonazepam 
in the third, cobalt(II), electrolyte for ionic 
strength and ethanol (total volume: 10 mL) in 
the fourth compartment. 
 
The vessel was thermostated at 22.00 ± 0.02 
°C and the reaction was initiated by 
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vigorously shaking the reactants. The 
reaction solution was transferred to a cell, 
and the absorbance at 425 nm was 
measured spectrophotometrically every 30 s 
over a period of 5 - 6 min (after mixing) 
against the reagent blank prepared similarly. 
The rate of the reaction ( dtdc / ) at different 
concentrations of each of the reactants was 
obtained by measuring the slope of the linear 
part of the kinetic curves to the absorbance-
time plot (from Beer`s law): 








/ , dtdArateslope /=≡ . 
The calibration graph was constructed by 
plotting the slope of the linear part of the 
kinetic curve versus the concentration of CZP 




Procedure for tablets  
 
A total of twenty tablets of each of different 
pharmaceutical formulations containing CZP 
were weighed and finely powdered using a 
mortar and pestle. An accurately weighed 
portion of the resulting powder, equivalent to 
2 mg of CZP, was dissolved in 25 mL of 
ethanol. The mixture was centrifuged at 3500 
rpm for 5 min, filtered through a 0.45 µm 
membrane filter (Millipore) directly into a 50 
mL volumetric flask and made up to volume 
with ethanol to obtain a solution of theoretical 
CZP concentration of 40.0 µg mL
-1
. Aliquots 
of this solution were transferred into vessels 
spanning the concentration range listed in 
Table 4. In all cases, it was assumed that the 
actual content of the tablet corresponds to 
the labelled strength of the products. 
. 
Serum sample preparation 
 
Human lyophilised serum (Lyotrol N) was 
used. The serum sample was spiked at one 
concentration level listed in Table 5. To 0.5 
mL of serum, the appropriate amount of the 
stock solution of CZP (1.0 mg mL
-1
) and 25 
mL of ethanol was added; after brief vortex 
mixing, it was centrifuged for 5 min at 3000 
rpm to separate the protein precipitate. The 
supernatant was collected in a 50 mL 
standard volumetric flask and filled up to the 
mark with the same solvent. The serum 
sample contained 200.0 µg mL
-1
 of CZP. 
Aliquots of this solution were transferred into 
vessels spanning the concentration range 
listed in Table 5. For kinetic determination, 
Fe
3+
 ions were masked by adding the 







). For HPLC determination, 
aliquots of CZP solution were transferred to a 
10 mL volumetric flask, evaporated to 
dryness in a water bath, the residue 
reconstituted with mobile phase, and then 10 
µL transferred to a glass vial for automatic 




HPLC method [2] was used for accuracy 
evaluation. Clonazepam was detected and 
quantified on a 250 x 4.6 mm Zorbax C18 
(5µm) analytical column operating at room 
temperature. The mobile phase was a 
mixture of tetrahydrofuran-methanol-water, 
10:42:48 (v/v/v)). The eluate was monitored 
at 254 nm. Injection of the samples (10 µL) 
was performed using an autosampler. Flow 






Data were reported as mean ± standard 
deviation (SD) for five determinations. 
Statistical analysis was performed by Student 
t-test and F-test at 95 % confidence level, 
using a statistical package (Statistica 8.0, 




Mechanism of the reaction 
 
Clonazepam shows complexing ability with 
Co(II) [14]. The complex agrees with the 
formula ( )
23
CZPCo . Its cobalt complex 
chelate is more stable than that formed with 
R(NO)OH and the equilibrium of the reaction 
moves towards the formation of this complex 
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. CZP was determined by monitoring the rate 
of appearance of 1-nitroso-2-naphthol in 
basic medium at 425 nm.  
( )[ ] [ ] ( )OHNORCZPCoCZPOHONORCo 6223 2322 +→+⋅  
Thus by measuring the absorbance change 
of the reaction mixture at the R(NO)OH 
maximum wavelength (λ = 425 nm) the 
concentration of CZP can be measured 
according to a calibration graph. The plot of 
the reaction rate as a function of the 
clonazepam concentration is a straight line 




A tangent method was used for processing 
the kinetic data. The rate of the reaction 
( dtdc / )  at different concentrations of each 
of the reactants was obtained by measuring 
the slope of the linear part of the kinetic 









/ , slope = dA/dt). 
 
Effect of variables 
 
In order to find the optimum experimental 
conditions for the determination of 
clonazepam, the kinetics of the indicator 
reaction proposed was studied.  
 
The dependence of the reaction rate on the 
alkalinity of the solution examined in the 





constant when the concentration of sodium 










was, therefore, selected for further 
work. 
 
The effect of the concentration of 1-nitroso-2-
naphthol on the rate of reaction was studied 





reaction rate increased linearly with increase 










 R(NO)OH, the rate remained 





 was selected as optimal for further 
investigation. 
 
The influence of the concentration of Co(II) 





. The reaction rate 
increased with increasing concentration of 










 was recommended for the 
determination process. 
 
The effect of temperature on the reaction rate 
was studied in the range 19 – 31 
0
C. The 
absorbance-time curves obtained at these 
temperatures indicated the temperature 
dependence of the reaction rate. The rate for 
different concentrations of CZP at each 
temperature was calculated and utilized for 
plotting the calibration curve 
( dtdArateslope /=≡ ). It was found that 
the calibration graph obtained at 22 
0
C 
possessed good linearity and it was 
recommended that the determination can be 




For the validation process, the following 
parameters were characterized [3]: linearity 
and range; limit of detection; repeatability; 
percent recoveries; precision; selectivity. The 
least squares
'
 equation [15] (y = bx + a, 
where b and a are slope and intercept, 
respectively) for the calibration graph and 
correlation coefficient (r) for the determination 
of CZP in the interval 0.32 to 4.1 µg mL
-1 
under the optimal reaction conditions 












, t = 
22.00±0.02 °C) were calculated: 
93235.075881.010
3
+⋅=⋅ CZPcslope   
( 9985.0=r ) ..................................... (1)                   
where slope is the slope of the linear part of 
the kinetic curve to the absorbance-time plot 
( dtdcldtdAslope // ⋅⋅== ε , Beer’s law) 
and CZPc  is clonazepam concentration 
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The variance (
2
0S ) of the calibration line was 







quantitative parameters of the analysis are 
given in Table 1. 
 














































The kinetic equation (Eq 3) for the reaction 
was deduced on the basis of the kinetics of 







CZPckrate ⋅= ........................................... (3)                                                                                
where k is the constant proportional to the 
rate constant of the reaction. The equation is 



















The limit of detection (LOD) [16] was 
evaluated using Eq 4: 
bSLOD /3.3 0×=  ................................ (4) 
where 0S  is the residual standard deviation 
of the calibration line, b is the slope of the 
calibration line (analytical sensitivity) and 




The precision and accuracy of the proposed 
method was studied by performing the 
experiment 5 times at three different 
concentration levels (low, medium and high) 
of clonazepam. The results are shown in 
Table 2.  
 






















(%)   
0.32
 
0.33 ± 0.01 3.39 103.12 
2.21
 
2.15 ± 0.04 2.08 97.28 
4.1
 
3.99 ± 0.06 1.53 97.32 
(*)
Mean and standard deviation of five 
determinations and 95 % confidence  
(**)
relative standard deviation 
 
The effect of temperature on reaction rate is 
well known and is important in understanding 
the various activation parameters of the 
reaction products. In order to evaluate the 
apparent activation parameters, the reaction 
rate was studied in the range 19 – 31 
0
C at 


















. Arrhenius curve was 
constructed by plotting log k versus 1/T and 
found to be linear with a coefficient of 
correlation, r = 0.9998. Activation energy (Ea) 
was calculated from the slope (-Ea/2.303R) 






To assess the selectivity of the method, a 
systematic study of the possible interferences 
by those species accompanying CZP in 
pharmaceuticals was carried out. The 
criterion of interference was fixed at 5 % 
variation of the average slope change 
measured (n = 5) for the established level of 
clonazepam. The tolerance limits (expressed 
as w/w ratio) for the species studied on the 
determination of 2.21 µg mL
-1
 of CZP are 
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Applicability of the proposed method 
 
In order to test the analytical validity of this 
approach, the proposed method was applied 
to the determination of clonazepam in 
pharmaceutical formulations and human 
serum using the direct calibration curve. They 
were treated as described in the 




The developed method under the optimal 













, t = 22.00±0.02 °C) showed 
statisfactory standard deviation, relative 
standard deviation (from 3.39 to 1.53 %) and 
mean percent recoveries (from 103.12 % to 
97.32 %). The least-squares regression 
analysis used to evaluate the concentration 
range data indicate linearity over the interval 
studied (0.32 - 4.1 mg mL
-1
). The correlation 
coefficient obtained for this clonazepam 
concentration range was 0.9985. The low 







negligible scattering of the experimental data 
points around the line of regression. The LOD 
value of 0.24 µg mL
−1 
indicate that the 
method is sensitive. 
 
Table 3: Tolerance ratio for foreign species in the determination of 2.21 µg mL
-1






































Met, Tyr, Trp, Phe, Asp, Ala, Ser 
 







10 – 15 
5 - 10 
< 5 
 





















Interference coefficient, I = (c
º




CZP and cCZP are measured concentrations of 
CZP without and with the interfering species; 
(**)






Table 4: Determination of clonazepam in commercial tablet formulation by the proposed method 















































3.44 ± 0.05 1.44 99.13 3.41 ± 0.04 1.68 1.078 
(*)
Data are based on the average obtained from five determinations 
(**)
Theoretical F-value (ν1=4, ν2=4) and t-value (ν=8) at 95 % confidence level are 6.39 and 2.306, respectively 
(***)
Tablets (from Galenika a.d., Belgrade, Serbia) containing clonazepam 2 mg and excip. 
(****)
Tablets (from La Roche, Switzerland) containing clonazepam 2 mg and excip. 
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0.32 0.30 ± 0.02 4.88 93.75 0.28 ± 0.01 1.26 1.976 
0.95 0.92 ± 0.03 2.34 96.84 0.91 ± 0.02 1.91 1.090 
(*)
Data are based on the average obtained from five determinations 
(**)
Theoretical F-value (ν1=4, ν2=4) and t-value (ν=8) at 95 % confidence level are 6.39 and 2.306, 
respectively 
 
The ability to predict changes in the rate of 
the reaction is based on a knowladge of the 
value of the activation energy. According to 
Hammond [17] and Smith [18], most 
reactions which have observable rates at 
ordinary temperatures have activation 





). A value of  92.45 kJ mol
-1
 obtained 
in this study, according to this postulate, 
indicates that the reaction is feasible. 
 
The presence of the usual powdery 
excipients (fructose, glucose, and lactose) 
and some amino acids (Met, Tyr, Trp, Phe, 
Asp, Ala, Ser) did not interfere with the 
method, The amounts of these additives used 
are usually much higher than those present in 
pharamceuticals and human serum. It should 
also be noted that a higher tolerance level to 
the presence of vitamins B1, B6 and B12 









, interfered when present in 
approximately 10-fold in excess. Some amino 
acids (His, Arg, Lys, Gly) interfered with the 





 ions. No 
interference was found when up to 100-fold 







 ions were included. 
 
As can be seen in Table 4, the results 
obtained by this method are in accordance 
with the HPLC method. Also, good recovery 
was observed in the case of serum sample 
(Table 5), indicating that the constituents of 
the human serum do not interfere, Fe
3+
 ions 
were masked with F
-
 and the protein was 
precipitated, in any case, with the detection of 
clonazepam. 
 
The results of the proposed method were 
statistically compared with those of the HPLC 
method using a point hypothesis test. 
Statistical analysis of the results (Tables 4 
and 5) showed that calculated F- and t-values 
at 95 % confidence levels were less than the 
theoretical ones, confirming no significant 
differences between the performance of the 
proposed and the HPLC method. Therefore, 
the proposed method could be used for the 
determination of clonazepam in pharma-




The proposed kinetic-spectrophotometric 
method for the determination of CZP in 
pharmaceutical samples and human serum 
reported in this work is simple, rapid, 
inexpensive, and thus appropriate for routine 
quality control analyses of the active drug in 
the laboratories of hospitals, pharmaceutical 
industries and research institutions. It should 
also be suitable for developing countries. The 
validation of the method shows that the 
results obtained are in good agreement with 
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